Role of EGFR as prognostic factor in head and neck cancer patients treated with surgery and postoperative radiotherapy: proposal of a new approach behind the EGFR overexpression-Reference-Cited by-同舟云学术

Role of EGFR as prognostic factor in head and neck cancer patients treated with surgery and postoperative radiotherapy: proposal of a new approach behind the EGFR overexpression

Published:2017-04-27 Issue:6 Volume:34 Page:
ISSN:1357-0560
Container-title:Medical Oncology
language:en
Short-container-title:Med Oncol

Author:

Alterio Daniela^ORCID,Marvaso Giulia,Maffini Fausto,Gandini Sara,Chiocca Susanna,Ferrari Annamaria,Preda Lorenzo,Rocca Maria Cossu,Lepanto Daniela,Fodor Cristiana,Volpe Stefania,Dicuonzo Samantha,Laudati Antonio,Giugliano Gioacchino,Ansarin Mohssen,Jereczek-Fossa Barbara A.

Funder

Merck serono

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Hematology,General Medicine

Link

http://link.springer.com/article/10.1007/s12032-017-0965-7/fulltext.html

Reference30 articles.

1. Warnakulasuriya S. Global epidemiology of oral and oropharyngeal cancer. Oral Oncol. 2009;45(4–5):309–16.

2. Pulte D, Brenner H. Changes in survival in head and neck cancers in the late 20th and early 21st century a period analysis. Oncologist. 2010;15(9):994–1001.

3. Bonner JA, Harari PM, Giralt J, Cohen RB, et al. Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival. Lancet Oncol. 2010;11(1):21–8.